8-K ·Filed Jun 2, 2026
8-K context-dependent: Items 5.02
Actionable Insight • Neutral
Routine board appointments with no material financial or strategic impact. No immediate trading action warranted.
Final — all horizons settled through T+60d
ACHV ▲ +64.41% at T+60d
NEUTRAL call +64.41% · α vs SPY +63.30% · entry $5.03 → $8.27
T+1d
-2.19%
call -2.19% · α -1.49%
$4.92
settled 5mo ago
T+5d
+11.33%
call +11.33% · α +14.30%
$5.60
settled 5mo ago
T+20d
+27.24%
call +27.24% · α +28.80%
$6.40
settled 4mo ago
T+60d
+64.41%
call +64.41% · α +63.30%
$8.27
settled 2mo ago
Price Chart
Loading chart...
Executive Summary
Achieve Life Sciences appointed Jeff Farrow and Dr. Reid Waldman as directors effective May 29, 2026. Both receive standard non-employee director compensation: a pro-rated $40,000 annual retainer and options for 47,250 shares vesting over three years. This is a routine board expansion with no unusual terms or departures.
Key Facts
- Jeff Farrow and Reid Waldman, M.D. appointed to the board on May 29, 2026.
- Farrow appointed to Nominating/Governance Committee and as Audit Committee Chair.
- Waldman appointed to Commercial Committee and as Compensation Committee Chair.
- Each new director receives pro-rated $40,000 annual retainer and 47,250 stock options vesting monthly over three years.
- Standard indemnification agreements entered into with each director.
Financial Impact
Not specified
Market Snapshot
Exchange
Nasdaq
Sector
In Vitro & In Vivo Diagnostic Substances
Analyst Consensus
93% bullish (14 analysts)
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-252624 |
| Document: 0001193125-26-252624-index-headers.html | 0001193125-26-252624 |
| Document: 0001193125-26-252624-index.html | 0001193125-26-252624 |
| Document: 0001193125-26-252624.txt | 0001193125-26-252624 |
16 reports for ACHV
75% Hit rate @ T+1 Went positive at some point 8 of 8 best @ T+60▲ +62.92%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 6, 2026 19d ago | 3 | $7.24 $7.19 | ▼ −0.69% | ▼ −0.27% | $6.52 (−9.94%) |
Oct 1, 2026 24d ago | 8-K | $7.24 $7.01 | ▼ −3.18% | ▼ −3.85% | $6.52 (−9.94%) |
Aug 14, 2026 10w ago | 8-K | $7.50 $7.52 | ▼ −0.27% | ▼ −0.94% | $6.52 (+13.07%) |
Aug 11, 2026 10w ago | 8-K | $6.69 $7.25 | ▲ +8.37% | ▲ +7.67% | $6.52 (−2.54%) |
Aug 11, 2026 10w ago | Press Release | $6.77 $6.69 | ▲ +1.18% | ▲ +1.43% | $6.52 (+3.69%) |
Aug 7, 2026 11w ago | Institutional Cluster | $6.65 $6.67 | ▲ +0.30% | ▲ +0.33% | $6.52 (−1.95%) |
Jun 11, 2026 19w ago | Institutional Cluster | $5.52 $5.52 | · 0.00% | ▲ +0.54% | $6.52 (−18.12%) |
Jun 2, 2026 20w ago | 8-K | $5.03 $4.92 | ▼ −2.19% | ▼ −1.49% | $6.52 (+29.62%) |
May 22, 2026 22w ago | EFFECT | $4.69 $4.56 | ▲ +2.77% | ▲ +3.36% | $6.52 (−39.02%) |
May 19, 2026 22w ago | Press Release | $4.45 $4.57 | ▲ +2.70% | ▲ +1.66% | $6.52 (+46.52%) |
Showing 10 of 16
US Market Status
Market Open — Closes in 19m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers